ID   UPP2_HUMAN              Reviewed;         317 AA.
AC   O95045; B3KV87;
DT   03-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   10-MAY-2017, entry version 136.
DE   RecName: Full=Uridine phosphorylase 2;
DE            Short=UPase 2;
DE            Short=UrdPase 2;
DE            EC=2.4.2.3;
GN   Name=UPP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CHARACTERIZATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=12849978; DOI=10.1016/S0006-291X(03)01062-3;
RA   Johansson M.;
RT   "Identification of a novel human uridine phosphorylase.";
RL   Biochem. Biophys. Res. Commun. 307:41-46(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.54 ANGSTROMS) OF 21-314, ENZYME REGULATION,
RP   AND DISULFIDE BOND.
RX   PubMed=21855639; DOI=10.1016/j.jsb.2011.08.002;
RA   Roosild T.P., Castronovo S., Villoso A., Ziemba A., Pizzorno G.;
RT   "A novel structural mechanism for redox regulation of uridine
RT   phosphorylase 2 activity.";
RL   J. Struct. Biol. 176:229-237(2011).
CC   -!- FUNCTION: Catalyzes the reversible phosphorylytic cleavage of
CC       uridine and deoxyuridine to uracil and ribose- or deoxyribose-1-
CC       phosphate. The produced molecules are then utilized as carbon and
CC       energy sources or in the rescue of pyrimidine bases for nucleotide
CC       synthesis. Shows substrate specificity and accept uridine,
CC       deoxyuridine, and thymidine as well as the two pyrimidine
CC       nucleoside analogs 5-fluorouridine and 5-fluoro-2(')-deoxyuridine
CC       as substrates.
CC   -!- CATALYTIC ACTIVITY: Uridine + phosphate = uracil + alpha-D-ribose
CC       1-phosphate.
CC   -!- ENZYME REGULATION: A conditional disulfide bridge can form within
CC       the protein that dislocates a critical phosphate-coordinating
CC       arginine Arg-100 away from the active site, disabling the enzyme.
CC       {ECO:0000269|PubMed:21855639}.
CC   -!- PATHWAY: Pyrimidine metabolism; UMP biosynthesis via salvage
CC       pathway; uracil from uridine (phosphorylase route): step 1/1.
CC   -!- INTERACTION:
CC       Q8IUQ4:SIAH1; NbExp=3; IntAct=EBI-10191025, EBI-747107;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O95045-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95045-2; Sequence=VSP_043756;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in kidney.
CC       {ECO:0000269|PubMed:12849978}.
CC   -!- SIMILARITY: Belongs to the PNP/UDP phosphorylase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH33529.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY225131; AAO61681.1; -; mRNA.
DR   EMBL; AK122743; BAG53699.1; -; mRNA.
DR   EMBL; AC005539; AAD12227.1; -; Genomic_DNA.
DR   EMBL; BC033529; AAH33529.1; ALT_INIT; mRNA.
DR   CCDS; CCDS2207.1; -. [O95045-1]
DR   CCDS; CCDS46435.1; -. [O95045-2]
DR   RefSeq; NP_001128570.1; NM_001135098.1. [O95045-2]
DR   RefSeq; NP_775491.1; NM_173355.3. [O95045-1]
DR   UniGene; Hs.128427; -.
DR   PDB; 2XRF; X-ray; 2.30 A; A/B/C=23-317.
DR   PDB; 3P0E; X-ray; 2.00 A; A/B/C/D/E/F=21-314.
DR   PDB; 3P0F; X-ray; 1.54 A; A=21-314.
DR   PDBsum; 2XRF; -.
DR   PDBsum; 3P0E; -.
DR   PDBsum; 3P0F; -.
DR   ProteinModelPortal; O95045; -.
DR   SMR; O95045; -.
DR   BioGrid; 127387; 3.
DR   IntAct; O95045; 2.
DR   STRING; 9606.ENSP00000387230; -.
DR   DrugBank; DB00544; Fluorouracil.
DR   DrugBank; DB05041; RP101.
DR   iPTMnet; O95045; -.
DR   PhosphoSitePlus; O95045; -.
DR   BioMuta; UPP2; -.
DR   PaxDb; O95045; -.
DR   PeptideAtlas; O95045; -.
DR   PRIDE; O95045; -.
DR   DNASU; 151531; -.
DR   Ensembl; ENST00000005756; ENSP00000005756; ENSG00000007001. [O95045-1]
DR   Ensembl; ENST00000605860; ENSP00000474090; ENSG00000007001. [O95045-2]
DR   GeneID; 151531; -.
DR   KEGG; hsa:151531; -.
DR   UCSC; uc002tzp.4; human. [O95045-1]
DR   CTD; 151531; -.
DR   DisGeNET; 151531; -.
DR   GeneCards; UPP2; -.
DR   HGNC; HGNC:23061; UPP2.
DR   HPA; HPA035225; -.
DR   HPA; HPA035226; -.
DR   MIM; 617340; gene.
DR   neXtProt; NX_O95045; -.
DR   OpenTargets; ENSG00000007001; -.
DR   PharmGKB; PA134866434; -.
DR   eggNOG; KOG3728; Eukaryota.
DR   eggNOG; COG2820; LUCA.
DR   GeneTree; ENSGT00390000004400; -.
DR   HOGENOM; HOG000231747; -.
DR   HOVERGEN; HBG047725; -.
DR   InParanoid; O95045; -.
DR   KO; K00757; -.
DR   OMA; FHIVERM; -.
DR   OrthoDB; EOG091G0EIO; -.
DR   PhylomeDB; O95045; -.
DR   TreeFam; TF314310; -.
DR   BRENDA; 2.4.2.3; 2681.
DR   Reactome; R-HSA-73614; Pyrimidine salvage reactions.
DR   Reactome; R-HSA-73621; Pyrimidine catabolism.
DR   SABIO-RK; O95045; -.
DR   SignaLink; O95045; -.
DR   UniPathway; UPA00574; UER00633.
DR   EvolutionaryTrace; O95045; -.
DR   GenomeRNAi; 151531; -.
DR   PRO; PR:O95045; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000007001; -.
DR   CleanEx; HS_UPP2; -.
DR   ExpressionAtlas; O95045; baseline and differential.
DR   Genevisible; O95045; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0045098; C:type III intermediate filament; IDA:UniProtKB.
DR   GO; GO:0004850; F:uridine phosphorylase activity; IDA:UniProtKB.
DR   GO; GO:0009116; P:nucleoside metabolic process; NAS:UniProtKB.
DR   GO; GO:0009166; P:nucleotide catabolic process; IEA:InterPro.
DR   GO; GO:0046135; P:pyrimidine nucleoside catabolic process; TAS:Reactome.
DR   GO; GO:0043097; P:pyrimidine nucleoside salvage; TAS:Reactome.
DR   GO; GO:0044206; P:UMP salvage; IEA:UniProtKB-UniPathway.
DR   GO; GO:0046108; P:uridine metabolic process; NAS:UniProtKB.
DR   InterPro; IPR018016; Nucleoside_phosphorylase_CS.
DR   InterPro; IPR000845; Nucleoside_phosphorylase_d.
DR   InterPro; IPR010059; Uridine_phosphorylase_euk.
DR   Pfam; PF01048; PNP_UDP_1; 1.
DR   SUPFAM; SSF53167; SSF53167; 1.
DR   TIGRFAMs; TIGR01719; euk_UDPppase; 1.
DR   PROSITE; PS01232; PNP_UDP_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Disulfide bond;
KW   Glycosyltransferase; Polymorphism; Redox-active center;
KW   Reference proteome; Transferase.
FT   CHAIN         1    317       Uridine phosphorylase 2.
FT                                /FTId=PRO_0000063193.
FT   DISULFID     95    102       Redox-active.
FT                                {ECO:0000269|PubMed:21855639}.
FT   VAR_SEQ       1      1       M -> MLAPGCELDPDQEVVRTRPEDVPASPSTSTMIVSVL
FT                                RPPSHASCTACGTVTFHIVERM (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043756.
FT   VARIANT      10     10       R -> S (in dbSNP:rs6710480).
FT                                /FTId=VAR_024431.
FT   VARIANT      78     78       M -> L (in dbSNP:rs7561584).
FT                                /FTId=VAR_034580.
FT   CONFLICT    153    153       I -> M (in Ref. 1; AAO61681).
FT                                {ECO:0000305}.
FT   CONFLICT    157    157       T -> R (in Ref. 1; AAO61681).
FT                                {ECO:0000305}.
FT   CONFLICT    256    262       ESTVFAA -> GIYSVCS (in Ref. 1; AAO61681).
FT                                {ECO:0000305}.
FT   HELIX        32     34       {ECO:0000244|PDB:3P0F}.
FT   HELIX        41     43       {ECO:0000244|PDB:3P0F}.
FT   TURN         47     49       {ECO:0000244|PDB:3P0F}.
FT   HELIX        52     56       {ECO:0000244|PDB:3P0F}.
FT   STRAND       61     66       {ECO:0000244|PDB:3P0F}.
FT   HELIX        68     82       {ECO:0000244|PDB:3P0F}.
FT   HELIX        88     90       {ECO:0000244|PDB:3P0E}.
FT   TURN         94     97       {ECO:0000244|PDB:3P0E}.
FT   STRAND       98    100       {ECO:0000244|PDB:3P0F}.
FT   STRAND      103    106       {ECO:0000244|PDB:3P0F}.
FT   STRAND      109    113       {ECO:0000244|PDB:3P0F}.
FT   HELIX       118    134       {ECO:0000244|PDB:3P0F}.
FT   STRAND      141    153       {ECO:0000244|PDB:3P0F}.
FT   STRAND      158    165       {ECO:0000244|PDB:3P0F}.
FT   STRAND      171    177       {ECO:0000244|PDB:3P0F}.
FT   STRAND      180    185       {ECO:0000244|PDB:3P0F}.
FT   HELIX       190    201       {ECO:0000244|PDB:3P0F}.
FT   STRAND      208    215       {ECO:0000244|PDB:3P0F}.
FT   HELIX       221    223       {ECO:0000244|PDB:3P0F}.
FT   STRAND      226    229       {ECO:0000244|PDB:3P0F}.
FT   HELIX       235    248       {ECO:0000244|PDB:3P0F}.
FT   STRAND      250    256       {ECO:0000244|PDB:3P0F}.
FT   HELIX       257    266       {ECO:0000244|PDB:3P0F}.
FT   STRAND      270    280       {ECO:0000244|PDB:3P0F}.
FT   TURN        281    283       {ECO:0000244|PDB:3P0F}.
FT   HELIX       291    298       {ECO:0000244|PDB:3P0F}.
FT   HELIX       300    313       {ECO:0000244|PDB:3P0F}.
SQ   SEQUENCE   317 AA;  35527 MW;  69F6BA1DC44977A3 CRC64;
     MASVIPASNR SMRSDRNTYV GKRFVHVKNP YLDLMDEDIL YHLDLGTKTH NLPAMFGDVK
     FVCVGGSPNR MKAFALFMHK ELGFEEAEED IKDICAGTDR YCMYKTGPVL AISHGMGIPS
     ISIMLHELIK LLHHARCCDV TIIRIGTSGG IGIAPGTVVI TDIAVDSFFK PRFEQVILDN
     IVTRSTELDK ELSEELFNCS KEIPNFPTLV GHTMCTYDFY EGQGRLDGAL CSFSREKKLD
     YLKRAFKAGV RNIEMESTVF AAMCGLCGLK AAVVCVTLLD RLDCDQINLP HDVLVEYQQR
     PQLLISNFIR RRLGLCD
//
